About IM Cannabis Corp. 
IM Cannabis Corp.
Pharmaceuticals: Other
IM Cannabis Corp., formerly Navasota Resources Inc., is a Canada-based medical cannabis company. The company is focused on offering a full spectrum of government-licensed cannabis products, from generic to good manufacturing practice (GMP) certified and pharmaceutical-grade, for both wholesale and retail clients. The Company operates in the Israeli medical cannabis market by providing intellectual property and services to licensed producers. The Company has three wholly-owned subsidiaries: IMC, incorporated, IMC Portugal and IM Cannabis Canada Inc. The Company also has four partially-owned subsidiaries Adjupharm GmbH, IMC Ventures Ltd., Societe Amig Navasota Mining International S.A.R.L., and Africa Bauxite Corporation.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 22 Foreign Institutions (6.99%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. James Gillis
Chairman of the Board, President, Chief Executive Officer
Mr. Navjit Dhaliwal
Director
Mr. Timothy Towers
Director
Mr. Russell Williams
Independent Director
Revenue and Profits:
Net Sales:
12 Million
(Quarterly Results - Mar 2025)
Net Profit:
0 Million
Pharmaceuticals: Other
CAD 16 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
2.65
-109.22%
2.96






